Skip to content
Clinical Trials – home
Pohjois-Pohjanmaan hyvinvointialue
Sponsor

Pohjois-Pohjanmaan hyvinvointialue

Finland Kajaanintie 50, 90220 Oulu, Finland

About the sponsor

Research activity includes less invasive surfactant administration and premedication strategies for newborns with respiratory distress syndrome, with attention to safety and tolerance of procedural care.

  • Surfactant treatment
  • Ketamine and fentanyl premedication
  • Adverse event reduction

The clinical focus is on neonatal support in intensive care settings and the optimisation of respiratory interventions.

About Specializations

Pohjois-Pohjanmaan hyvinvointialue runs clinical trials in conditions such as Contraception, Urinary tract infection, Acute respiratory distress syndrome, Metabolic syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Escherichia Coli Strain Nissle 1917
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Fentanyl Citrate
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Metabolic syndrome

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Placebo
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).